Industry Collaboration Group member since 2015
Community Engagement Coordinator DARE MDC
AIDS Action Baltimore, Executive Director
HIV and AIDS treatment activist Lynda Dee co-founded AIDS Action Baltimore in 1987 after the death of her husband and two-thirds of her friends as a result of AIDS-related complications. She has worked for 35 years with academia, industry and government to expedite ethical drug development to provide access to life-saving medications before approval and to ensure reasonable drug prices and increases. She works in the HIV cure research arena and has served as Co-Chair of the Martin Delaney Collaboratory (MDC) CARE Community Advisory Board (CAB), and Co-Chair of the amfAR Cure Institute CAB. She is now the DARE MDC Community Engagement Coordinator.
Lynda has served on many national and local community and government advisory boards. She has been a member of various FDA Antiviral Drugs Advisory approval panels and many NIH advisory boards, including NCI, the Office of AIDS Research Advisory Committee, NIMH, NIDS, NIDA and NIAID, serving on the ACTG Executive Committee and its Community Constituency Group. She has also served on various industry HIV and HCV CABs and national and international CAB advisory boards, including the AIDS Treatment Activist Coalition. Lynda is also a former Chair and current member of the Fair Pricing Coalition. She has been a member of the executive committee and frequent presenter for the Forum for Collaborative HIV Research and a member of the IAS Industry Collaboration Group.